ArticleTranslational pediatrics2025
Cardiac arrhythmia, developmental delay, epilepsy and ichthyosis due to Xp22.31 deletion: review of literature and case report.
Article in Translational pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prenatal diagnosis and molecular cytogenetic analysis of Xp22.31 microdeletions and microduplications in Chinese populations.BMC pregnancy and childbirth · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The broad phenotypic variability observed in patients with Xp22.31 deletion, traditionally associated with X-linked ichthyosis (XLI), is increasingly recognized as encompassing a wider spectrum of clinical manifestations. While ichthyosis, caused by Case Description: We describe three unrelated male patients carrying hemizygous Xp22.31 microdeletions (~1.6 Mb), all presenting with mild to moderate ichthyosis characterized by "plate-like" desquamation. Two patients exhibited intellectual disability and bradyarrhythmia, while one experienced seizures. None had major congenital anomalies, and all underwent chromosomal microarray analysis to confirm the diagnosis. Conclusions: Our findings emphasize the need for a multidisciplinary approach when evaluating patients with Xp22.31 deletions, extending beyond dermatologic assessment to include neurological and cardiological evaluations, even in the absence of overt symptoms. This broader phenotypic understanding may enhance clinical management, support more accurate genetic counseling, and inform prenatal diagnostic decision-making. Furthermore, our observations support the hypothesis that genes within the deleted region-such as
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.